5AM Ventures VI is a Venture Capital Fund in California with $515.48 mm assets under management. It has 86 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$515.48 mm
Address
5AM Ventures VI
501 SECOND STREET, SUITE 350
SAN FRANCISCO
CA 94107
501 SECOND STREET, SUITE 350
SAN FRANCISCO
CA 94107
Phone
(650) 843-5000
Ownership
Fund structure | AUM | Fund type |
---|---|---|
5AM Ventures | $2.00 bn | |
5AM Co-investors II, LP | $1.11 mm | Venture Capital Fund |
5AM Co-investors III, LP | $1.21 mm | Venture Capital Fund |
5AM Co-investors IV, LP | $10.42 mm | Venture Capital Fund |
5AM Opportunities I, LP | $134.35 mm | Private Equity Fund |
5AM Opportunities II, LP | $293.27 mm | Private Equity Fund |
5AM Ventures II, LP | $25.80 mm | Venture Capital Fund |
5AM Ventures III, LP | $45.88 mm | Venture Capital Fund |
5AM Ventures IV, LP | $250.17 mm | Venture Capital Fund |
5AM Ventures V, LP | $283.74 mm | Venture Capital Fund |
5AM Ventures VI, LP | $515.48 mm | Venture Capital Fund |
5AM Ventures VII, LP | $441.48 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13D/A
Enliven Therapeutics, Inc.
15 Apr 24
4
Andrew J. Schwab
16 Feb 24
SC 13D/A
Enliven Therapeutics, Inc.
16 Feb 24
SC 13D/A
Vor Biopharma Inc.
14 Feb 24
4
Andrew J. Schwab
2 Feb 24
SC 13D/A
Enliven Therapeutics, Inc.
2 Feb 24
4
Andrew J. Schwab
28 Sep 23
4
Andrew J. Schwab
28 Aug 23
SC 13D/A
Enliven Therapeutics, Inc.
28 Aug 23
144
Enliven Therapeutics, Inc.
24 Aug 23